Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

VIVUS Inc (NASDAQ:VVUS)

0.9955
Delayed Data
As of Aug 21
 -0.0145 / -1.44%
Today’s Change
0.98
Today|||52-Week Range
1.47
-13.43%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$105.3M

Company Description

VIVUS, Inc. operates as a biopharmaceutical company engages in the development and commercialization of novel therapeutic products. It offers the Qsymia for chronic weight management, as well as STENDRA and SPEDRA for erectile dysfunction. Its development also include Tacrolimus which is for the treatment of Pulmonary Arterial Hypertension. The company was founded by Virgil A. Place on April 16, 1991 and is headquartered in Mountain View, CA.

Contact Information

VIVUS, Inc.
900 East Evelyn Avenue
Campbell California 95008
P:(650) 934-5200
Investor Relations:

Employees

Shareholders

Mutual fund holders4.86%
Other institutional30.93%
Individual stakeholders24.33%

Top Executives

Seth H. Z. FischerChief Executive Officer & Director
Mark K. OkiChief Financial & Accounting Officer
Santosh T. VargheseChief Medical Officer
Ted BromanVice President-Chemistry, Manufacturing & Control
Sandra E. WellsVice President-Patents & Assistant General Counsel